FindTrial
Sign In

To assess the untoward effect of 3 test product, in men with baldness

To evaluate the in-use tolerance of 3 topical solutions (Minoxidil 5 %), in men with androgenetic alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016431
Enrollment
90
Registered
2018-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Minoxidil Alcohol Free: Apply 1 ml on affected areas and spread it evenly. Apply a small amount at a time. Apply twice daily. Control Intervention1: Regaine 5%: Apply 1 ml on affected a

Sponsors

Dr Reddys Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Voluntary males with 18 years of age and above. Presence of androgenetic alopecia.

Exclusion criteria

Exclusion criteria: Scarring of the scalp or any other condition or disease of the scalp or hair. Participants with any cardiac abnormalities or ailments or abnormal blood pressure. Hypersensitivity to any cosmetic product, raw material. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).

Design outcomes

Primary

MeasureTime frame
Clinical assessment for redness and scaling Instrumental assessment for Hydration of scalp Subjective Self-assessment for in use skin tolerance Digital Photographs of scalp.Timepoint: Day 0, Day 15, Day 30—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Shivani Acharya

Dr. Reddys Laboratories Ltd.

shivaniacharya@drreddys.com07995015179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 18, 2026